These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31542611)

  • 1. Hyper-serotonergic state determines onset and progression of idiopathic Parkinson's disease.
    da Cruz Moreira-Junior E
    Med Hypotheses; 2019 Dec; 133():109399. PubMed ID: 31542611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts.
    Politis M; Wu K; Loane C; Quinn NP; Brooks DJ; Oertel WH; Björklund A; Lindvall O; Piccini P
    Sci Transl Med; 2012 Apr; 4(128):128ra41. PubMed ID: 22491951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
    Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR
    Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rapid-eye-movement sleep disorders in Parkinson's disease].
    Gagnon JF; Montplaisir J; Bédard MA
    Rev Neurol (Paris); 2002 Feb; 158(2):135-52. PubMed ID: 11965170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral habenula as a link between dopaminergic and serotonergic systems contributes to depressive symptoms in Parkinson's disease.
    Luo XF; Zhang BL; Li JC; Yang YY; Sun YF; Zhao H
    Brain Res Bull; 2015 Jan; 110():40-6. PubMed ID: 25499570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Degeneration of Both Dopaminergic and Serotonergic Axons - A Common Mechanism in Parkinson's Disease.
    Grosch J; Winkler J; Kohl Z
    Front Cell Neurosci; 2016; 10():293. PubMed ID: 28066188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.
    Kohl Z; Ben Abdallah N; Vogelgsang J; Tischer L; Deusser J; Amato D; Anderson S; Müller CP; Riess O; Masliah E; Nuber S; Winkler J
    Neurobiol Dis; 2016 Jan; 85():206-217. PubMed ID: 26523794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The habenula couples the dopaminergic and the serotonergic systems: application to depression in Parkinson's disease.
    Sourani D; Eitan R; Gordon N; Goelman G
    Eur J Neurosci; 2012 Sep; 36(6):2822-9. PubMed ID: 22774942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential subcellular location of mitochondria in rat serotonergic neurons depends on the presence and the absence of monoamine oxidase type B.
    Arai R; Karasawa N; Kurokawa K; Kanai H; Horiike K; Ito A
    Neuroscience; 2002; 114(4):825-35. PubMed ID: 12379239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT
    Ishii T; Kinoshita KI; Muroi Y
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
    Fox SH; Chuang R; Brotchie JM
    Prog Brain Res; 2008; 172():479-94. PubMed ID: 18772047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
    Mehler-Wex C; Riederer P; Gerlach M
    Neurotox Res; 2006 Dec; 10(3-4):167-79. PubMed ID: 17197367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease.
    Prinz A; Selesnew LM; Liss B; Roeper J; Carlsson T
    Exp Neurol; 2013 Oct; 248():236-45. PubMed ID: 23810738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia.
    Vegas-Suarez S; Paredes-Rodriguez E; Aristieta A; Lafuente JV; Miguelez C; Ugedo L
    Int Rev Neurobiol; 2019; 146():259-279. PubMed ID: 31349930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys.
    Gagnon D; Gregoire L; Di Paolo T; Parent M
    Brain Struct Funct; 2016 Sep; 221(7):3675-91. PubMed ID: 26462663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study.
    Doder M; Rabiner EA; Turjanski N; Lees AJ; Brooks DJ;
    Neurology; 2003 Feb; 60(4):601-5. PubMed ID: 12601099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic dysfunction in Parkinson's disease and its relevance to disability.
    Politis M; Loane C
    ScientificWorldJournal; 2011; 11():1726-34. PubMed ID: 22125431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.